Dublin, Jan. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5rzpcl/the_global) has announced the addition of the "The Global Glucose Monitoring Market" report to their offering.
Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, andcomplications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.
The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaks out the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in.
There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.
Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market.
A select few are discussed here, including:
- Abbott Laboratories
- AgaMatrix Arkray, Inc
- Bayer Diabetes Bionime Corporation
- DexCom, Inc.
- Echo Therapeutics
- Entra Health Systems LLC
- Fora Care Inc
- Genesis Health Technologies
- GlySure Limited
- Insulet
- Johnson & Johnson
- Medtronic
- Nipro Diagnostics, Inc
- Nova Diabetes Care, Inc.
- Oak Tree International Holdings, Inc
- Prodigy Diabetes Care, LLC
- Roche U.S. Diagnostics, Inc.
Key Topics Covered:
- Executive Summary
- Introduction
- Traditional Glucose Monitoring Devices And Diabetes Management Market
- Continuous Glucose Monitoring And Sensor Market
- Issues And Trends
- Global Glucose Monitoring Devices And Diabetes Management Market And Competitor Analysis
- Market Analysis By Region
- Corporate Profiles
For more information visit http://www.researchandmarkets.com/research/5rzpcl/the_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Glucose Testing, Diabetes Devices


Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 



